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Summary 
Consumption of nutrients and other bioactive compounds from food interact with numerous 
targets, metabolic pathways and physiological functions in the organism and hereby 
potentially reduce or increase the risk of diseases. Analytical methods that can handle 
multiple responses may therefore seem particular beneficial compared to the univariate 
approaches most often used in nutrition research. Metabolomics is a new technique that 
allows measuring a large number of metabolites present in a given biological sample and the 
metabolic effect of e.g. a specific food intake can hereby be explored in a more global way 
than with traditional methods.  
The aim of this project has been the establishment of a metabolomics platform utilising Mass 
Spectrometry (MS), Nuclear Magnetic Resonance (NMR) spectroscopy and chemometrics to 
investigate health potentials of apple and apple-pectin intake.  
An explorative metabolomics approach was employed in Paper I to identify exposure and 
effect markers of 24 Fisher rats fed a diet supplemented with fresh apple or apple-pectin for 4 
weeks. Urine was analyzed by liquid chromatography and mass spectrometry (LC-MS) and 
metabolites that responded to the apple or pectin diets were selected and classified as either 
exposure or effect markers based on response patterns. Quinic acid, m-coumaric acid and (-
)epicatechin were identified as exposure markers and hippuric acid as one of the effect 
markers of apple intake. Pyrrole-2-carboxylic acid and 2-furoylglycine were identified as 
pectin exposure markers while 2-piperidinone was recognized as a pectin effect marker. None 
of these metabolites have been related to intake of pectin or other fibre products before. The 
metabolism and potential health aspects of these markers are discussed in this paper. 
 
A targeted NMR-based metabolomics approach was employed in Paper II as an alternative, 
fast and reliable method to quantify cholesterol distribution in the different lipoprotein 
fractions in rats. Plasma from two rat studies (n = 68) was used in determining the lipoprotein 
profile by an established ultracentrifugation method and proton NMR spectra of replicate 
samples were obtained. From the ultracentrifugation reference data and the NMR spectra, 
interval partial least-square (iPLS) regression models were constructed in order to predict the 
amount of cholesterol in high, low and very low density lipoprotein (HDL, LDL and VLDL) 
as well as the total plasma cholesterol. The iPLS approach yielded fine regression models and 
was used to determine HDL, LDL, VLDL and total cholesterol in a study where 24 rats had 
been supplemented with two doses of apple-powder. A dose of 20% apple-powder 
significantly lowered HDL cholesterol. Thus, this method seems to be a strong and efficient 
way to quantify lipoprotein cholesterol in rat studies. 
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In Paper III the NMR-based PLS regression models developed in Paper II were used to 
investigate the cholesterol distribution in plasma lipoproteins in the same rat study as 
described in Paper I. Additionally, faecal bile acid excretion, plasma activities of selected 
hepatic enzymes and gene expression of antioxidant enzymes in the liver were investigated.  
LDL, HDL and total cholesterol as well as total and primary bile acids were significantly 
reduced in the apple group. Secondary bile acids showed a significant reduction after apple 
intake. Pectin did not exhibit any effects on cholesterol metabolism but significantly up-
regulated plasma alkaline phosphatase (AlP). Both apple and apple-pectin intake revealed 
significant effects on genes involved in the hepatic glutathione redox cycle, indicating a 
higher capability to handle oxidative stress.  
Overall, these investigations indicate that fresh apple may have health beneficial effects on 
cholesterol metabolism but from our results pectin cannot be appointed as the major decisive 
apple component that causes this effect. However, the investigations were conducted with rat 
models and it is important to stress cautious extrapolation to humans. The utilization of the 
MS and NMR-based metabolomics approaches have served as competent platforms during 
these studies and the metabolomics technology seems very promising in further unravelling of 
the interplay between dietary intake and health status.  
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Resumé 
Indtag af næringsstoffer og andre bioaktive stoffer fra fødevarer påvirker adskillige 
metaboliske processer og fysiologiske funktioner i organismen og kan herigennem potentielt 
øge eller minske risikoen for at udvikle sygdom. Analytiske metoder, der kan håndtere mange 
responser samtidigt, er derfor særligt attraktive i forhold til de univariate metoder, som oftest 
anvendes i ernæringsforskning. Metabolomics er en ny teknik, hvor ideen er at måle 
størsteparten af de stoffer/metaboliter, der er tilstede i en given biologisk prøve. Herved kan 
den metaboliske effekt af f.eks. en bestemt fødevare undersøges i en større helhed, end det er 
muligt med traditionelle metoder. 
Formålet med dette projekt har været at etablere en metabolomics platform, der anvender 
massespektrometri (MS), kernemagnetisk resonans (NMR) spektroskopi og kemometri for 
herigennem at undersøge sundhedsrelaterede egenskaber af æble og æble pektin.  
En eksplorativ metabolomics tilgang blev anvendt i Artikel I for at identificere eksponerings 
og effekt markører fra 24 Fisher rotter der havde indtaget en kost tilsat frisk æble eller æble 
pektin gennem 4 uger. Urinen blev analyseret vha. væske-kromatografi og massespektrometri 
(LC-MS), og metabolitter, der reflekterede kosten tilsat æble eller pektin, blev udvalgt og 
klassificeret som enten eksponerings eller effekt markører på baggrund af deres respons 
mønster. Quinasyre, m-cumarsyre og (-)epicatechin blev identificeret som eksponerings 
markører og hippursyre som en af effekt markørerne for æbleindtag. Pyrrol-2-carboxylsyre 
and 2-furoylglycin blev identificeret som pektin eksponerings markører, hvorimod 2-
piperidinon blev fundet som en effekt-markør. Ingen af disse har tidligere været relateret til 
indtag af pektin eller andre fiber produkter. Metabolismen og potentielle sundhedsmæssige 
aspekter af disse markører diskuteres i artiklen. 
  
En kvantitativ NMR-baseret metabolomics tilgang blev anvendt i Artikel II som en alternativ, 
hurtig og pålidelig metode til at kvantificere kolesterol-fordelingen i forskellige lipoprotein 
fraktioner i plasma fra rotter. Plasma fra to rottestudier (n = 68) blev anvendt til at bestemme 
lipoprotein profilen vha. en veletableret ultracentrifugerings metode og desuden blev proton 
NMR spektrer optaget af den samme prøve. Interval partial least-square (iPLS) regressions 
modeller blev opbygget ud fra ultracentrifugering reference data og fra NMR spektrene for at 
bestemme mængden af kolesterol i høj-, lav- og meget lav densitet lipoproteiner (HDL, LDL 
and VLDL) og total kolesterol i plasma. iPLS-metoden resulterede i gode regressions 
modeller, og blev brugt til at bestemme HDL, LDL, VLDL og total kolesterol i et forsøg, hvor 
24 rotter havde fået tilsat to doser af tørret æble pulver til fodret. En dosis på 20% æble pulver 
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reducerede signifikant HDL kolesterol. Den anvendte metode vurderes som en kompetent og 
effektiv måde at kvantificere kolesterol i de forskellige lipoprotein fraktioner i rotte studier. 
 
 I Artikel III blev de NMR-baserede PLS regressions–modeller, der var udviklet i Artikel II, 
brugt til at undersøge kolesterol-fordelingen i plasma lipoproteiner i det samme rottestudie, 
som er beskrevet i Artikel I. Derudover blev galdesyre udskillelse i fæces undersøgt samt 
aktiviteten af udvalgte plasma enzymer og genekspression af antioxidant enzymer i leveren. 
LDL, HDL and total kolesterol samt total og primære galdesyrer var signifikant reduceret i 
æble gruppen. Sekundære galdesyrer viste en signifikant sænkning efter æble indtag. Pektin 
havde ingen effekter på kolesterol metabolisme, men opregulerede signifikant alkalisk 
fosfatase (AlP) i plasma. Både æble- og pektin-indtag viste signifikante effekter på gener 
involveret i leverens glutathion redox cyklus, hvilket tolkes som en forbedret evne til at 
håndtere oxidativt stress.  
 
Forskningen præsenteret i denne afhandling antyder at indtag af frisk æble har fordelagtige 
helbredsmæssige effekter på kolesterol metabolisme, og ud fra resultaterne ser pektin ikke ud 
til at være den afgørende komponent i æble, der inducer denne effekt. Undersøgelserne 
præsenteret her er foretaget i rotter, og der må udvises forsigtighed med at overføre 
resultaterne direkte til mennesker. Anvendelsen af MS- og NMR-baseret metabolomics har i 
disse undersøgelser vist sig som kompetente analytiske platforme, og metabolomics 
teknologien som helhed vurderes som meget lovende i forhold til den fremtidige forståelse af 
samspillet mellem kost-indtag og sundhedsstatus.  
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1 Introduction 
1.1 Background 
The inter-play between dietary intake and disease has been investigated for many years with 
gradually more refined measuring methods being developed over time. Consumption of 
nutrients and other bioactive compounds from food will interact with numerous targets, 
metabolic pathways and functions in the organism and hereby potentially reduce or increase 
the risk of disease. Methods that can handle multiple responses may therefore be particularly 
beneficial compared to the classical univariate approaches most often used in nutrition 
research. Metabolomics is one of the latest developed approaches to access environmental 
influence on living systems, and this technique enables simultaneously measurement of large 
part of the metabolites present in a given biological sample, whereby the metabolic effect of 
e.g. a specific food intake can be explored in a more global way than with traditional methods 
(Scalbert et al., 2009). This offers a unique possibility to measure the real end-points of 
physiological regulatory processes, the metabolites, either by use of nuclear magnetic 
resonance (NMR) spectroscopy or mass spectrometry (MS) techniques and with subsequent 
exploration of the metabolic profiles with multivariate statistical analysis for biomarker 
identification. However, many factors may have a crucial influence on the final result and 
minimisation of unwanted sources of variation is very important in establishment of a reliable 
metabolomics platform. When this technology is properly established, the metabolomics 
approach may reveal new biomarkers, alterations in biochemical pathways and highlight 
associations between diet and disease risk. The measurement of metabolite profiles may also 
be applied profitably in a more targeted way to subtract quantitative information of a priori 
known effect markers, and the dual applicability of the metabolomics technology makes it a 
very suited and versatile tool in investigations of e.g. food intake and the corresponding 
physiological responses in living organisms.  
In this project apple was selected as the nutritional subject, and its physiological responses 
were explored by means of the metabolomics technique. Apple remains one of the most 
consumed fruits in the Western World, and the health impact from intake of this fruit seems 
particularly relevant to investigate. Apple has a historical reputation of being a healthy 
component as illustrated by the popular expression, “an apple a day keeps the doctor away”, 
and several lines of scientific evidence suggest that apple and apple products posses a wide 
range of biological activities that may contribute to health beneficial effects against cancer, 
asthma, obesity, diabetes and cardiovascular diseases (CVD) (Boyer & Liu, 2004). However, 
the active factors and mechanisms responsible for these potential health promoting actions 
still remain unclear. In particular, an inverse association between apple intake and cholesterol 
metabolisms seems convincing (Aprikian et al., 2001;Judd & Truswell, 1982;Sable-Amplis et 
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al., 1983a), and it has been reported that the cell wall polysaccharide, pectin, may be the 
fraction responsible for a lipid-lowering effect of apple consumption (Cara et al., 1993). 
Metabolomics analysis of biological samples from in vivo investigations of apple and pectin 
intake may shed new light on health aspects related to apple intake and assist in elucidation of 
mechanisms and bioactive components of this fruit.   
 
1.2 AiM of the thesis 
The purpose of this project has been establishment of a reliable metabolomics platform 
utilising MS, NMR spectroscopy and chemometrics to investigate effects of apple intake. The 
project was divided into the following parts: 
• Identify metabolomics exposure and effect markers of apple and pectin intake 
obtained from a rat experiment (Paper I). 
• Establish an NMR-based Partial Least Square (PLS) regression model for rapid and 
reliable quantification of the plasma lipoprotein profile in rats (Paper II). 
• Apply the NMR-based PLS regression model to the same rat study as in Paper I and to 
rats supplemented with apple-powder (Paper II). Hereby to investigate the effect on 
cholesterol metabolism of dried apple, fresh apple and pectin intake (Paper III). 
• Evaluate the health effects of apple intake through the biomarker identified 
    
 
1.3 Thesis outline 
The thesis consists of introductory part followed by three papers (Paper I, II and III). A co-
authoring paper (not yet published) is enclosed as supplemental material. Papers I and III are 
based on the same animal experiment. In the introductory part some experimental results from 
the papers are presented to highlight general concepts.   
Chapter1 emphasises the importance of novel tools in nutrition research, explains why apple 
was selected as the nutritional case and provides the general aims of the thesis.  
Chapter 2 serves as an introductory text to the field of metabolomics research and provides a 
brief theoretical background of the different methods used in this project as well as the 
considerations of ‘good practice’ when performing nutri-metabolomics experiments. 
Chapter 3 describes the chemical composition of an apple and the absorption, metabolism and 
potential mechanisms of action in relation to CVD of proposed bioactive apple components.  
13 
 
Chapter 4 provides an overview of results and discussion of Paper I, II and III and further 
considers aspects and reflections that did not found their way into the papers.    
Chapter 5 summarises with a conclusion of the thesis and provides the perspectives for the 
future use of metabolomics in nutrition research.  
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2 Metabolomics  
2.3 metabolomics in Nutrition studies 
Metabolomics is a term used to describe the study of small molecule intermediates and 
products of metabolism present in biofluids, tissues and cellular extracts. The word is coined 
in analogy with genomics and proteomics, and while these two terms reveal possible 
functions of a biological system, metabolomics represents its actual state (Giovane et al., 
2008). The word metabolome was introduced for the first time by Oliver et al. (1998) as the 
set of low-molecular-mass compounds synthesised by an organism. A few years later the term 
metabolomics was introduced, as the identification and quantification of every single 
metabolite in a biological system (Fiehn, 2002). The two terms metabolomics and 
metabonomics are often used intertwined. They were initially defined separately with origins 
in plant science and pharmacology, respectively, but in effect mean the same, and the word 
metabolomics is now more widely accepted (Metabolomics Society, 2010) and will be the 
term used in the ensuing sections. The word nutri-metabolomics is used in this thesis to cover 
in vivo metabolomics studies in relation to nutrition.  
The metabolome consists of a large number of small metabolites (< 1,500 Da) belonging to a 
variety of different compound classes, such as amino acids, peptides, organic acids, lipids, 
nucleotides etc. The exact number of metabolites from humans is unknown but is estimated to 
be around 20,000 with wide concentration ranges spreading over nine orders of magnitude 
(Giovane et al., 2008). Several players have an impact on the metabolome in humans and 
animal, and the metabolome can be divided into 1) the endogenous metabolome, which 
includes the metabolites produced by cells or tissues in the host, 2) the xenometabolome, 
which includes foreign metabolites derived from e.g. drugs and dietary compounds, 3) the 
food metabolome with the metabolites deriving from digestion of food and 4) the microbial 
metabolome produced by the gut microbiota (Manach et al., 2009). Altogether, this leaves a 
complex metabolome signature depending on genetics and on diet as well as environmental 
variations that the host has been exposed to. 
 The first published study in which the metabolomics approach was used in a nutritional 
experiment applied NMR technology to measure the effect of dietary soy supplementation 
(Solanky et al., 2003), and after this several other NMR-based nutri-metabolomics studies 
have been conducted e.g. Holmes et al. (2008), Lenz et al. (2004), Stella et al. (2006). MS-
based nutri-metabolomics had its beginning a little later with one of the first studies 
investigating polyphenol concentrations in human urine after intake of polyphenol-rich 
beverages (Ito et al., 2005), and more studies have followed (Paper I;Fardet et al., 
2008b;Fardet et al., 2008a;Shen et al., 2008;Gürdeniz et al., 2010). Typically, the different 
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types of metabolomics analysis can be separated into two major groups: non-targeted and 
targeted, depending on the aim of the research, and these approaches are briefly described 
below. 
 
2.3.1 Non-targeted analysis 
The non-targeted, or explorative, metabolomics approach provides a hypothesis-free global 
overview of abundant metabolites. During a non-targeted approach, the compounds are not 
initially identified, and the features of all potential compounds are considered for further 
analyses. This approach is often referred to as metabolic fingerprinting, since the intention is 
not to identify each observed metabolite, but instead to compare ‘fingerprints’ or patterns of 
changes in response to e.g. dietary intake or disease status (Dettmer et al., 2007). However, a 
completely ‘true’ non-targeted analysis is never possible, since the chosen analytical method 
and experimental perturbation always affects the metabolite outcome. After selection of 
metabolites of interest from the non-targeted analysis a more targeted approach is required for 
biological interpretation. Identification and to some extent quantification of the selected 
metabolites is necessary in order to provide biological insight and understanding of 
underlying mechanism of action.  
 
2.3.2 Targeted analysis 
The targeted metabolomics approach focus on identified metabolites or pre-selected metabolic 
pathways. The term targeted metabolomics analysis in this thesis covers what is sometimes 
called targeted analysis, targeted profiling or quantitative metabolomics in the literature. The 
central thing for these terms is that analytical peaks (or latent peak regions) are initially 
identified and subsequently quantified. This kind of analysis is characterised as a hypothesis-
driven approach rather than a hypothesis-generating. The term metabolic profiling is often 
used for a partly non-targeted approach where the metabolomics data are scanned for specific 
compounds normally collected in a reference library, but at least some of the metabolites may 
not be known in advance. However, the metabolic profiling approach is not used in this 
project and will not be consider further. 
  
2.4 The metabolomics pipeline 
To obtain fruitful and reliable results from metabolomics studies, numerous factors have to be 
carefully considered. These aspects are summarised in Figure 1, which illustrates the 
workflow of a metabolomics study. The following sections will consider the issues that need 
 special concern when working through the metabolomics pipeline
I-III will be given when appropriate
 
 
 
 
2.5 Study design and sampling strategies
2.5.1 Study design 
Selection of an adequate study design is a recurring 
however, the high dimensionality of 
types of studies. A general problem in metabolomics studies is the relative
samples compared to the number of 
problematic in data analysis and hereby in 
Therefore, the highest possible 
In nutri-metabolomics studies it seems particular
to the large diversity of compounds present in different food items.
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Figure 1: Illustration of the metabolomics pipeline, the workflow of a metabolomics study.  
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2.5.2 Sample collection 
Metabolomic experiments are most often designed to capture a snapshot of the metabolome, 
and the objective of sampling is to inhibit or stop metabolic flux to allow the snapshot to be 
representative of the metabolome before sampling. Therefore, great care must be taken to 
preserve the original information and variance in the biological sample, and any degradation 
of metabolites after sample collection should be avoided to the greatest possible extent, to 
ensure appropriate quantification and reproducibility among samples.  
The work included in this thesis explores urine and plasma samples analysed by ultra high 
pressure liquid chromatography quadropole time-of-flight MS (UPLC-QTOF-MS) and 1H 
NMR spectroscopy, and the best possible preservation procedures for these sample has been 
worked out as a compromise between the two analytical techniques. A proton-free 
preservative is preferred to limit interference with 1H NMR spectra, and addition of NaN3 was 
selected as the urinary preservative (Paper I) as recommended from investigations by 
Lauridsen et al. (2007). This was confirmed by Saude & Sykes (2007), who showed that 
NaN3 reduced the changes in metabolite concentration when urine was kept at room 
temperature. Addition of NaN3 to the sample collection devise (as described in Paper I) is only 
possible prior to collection in animal studies and not in human studies, due to safety issues of 
this highly toxic chemical. Urine will most often be contaminated with microorganisms, and 
the added preservative, but also cooled conditions, will minimise the microbial conversion of 
metabolites and in this way keep them representative for the biological situation they 
originally derived from. Keeping the urine below 5˚C is recommended (Maher et al., 2007) 
and a urinary cooling method was developed for collection of 24 hour rat urine as described in 
Paper I.    
When considering blood sample collection, the microbial aspect is less important, but instead 
enzymatic metabolite degradation may be pronounced. Blood samples should therefore be 
handled as cold as possible to preserve the metabolic snapshot in the most optimal way. For 
plasma samples, the anticoagulant to be used must be considered carefully, hereby avoiding 
possible unwanted peaks in the mass or NMR spectrum and additionally reducing oxidation 
of plasma to the highest possible extent. EDTA, heparin and citrate are the normal 
anticoagulants to choose from. Heparin is the preferred plasma anticoagulant to be used in 
NMR-based metabolomics experiments due to low introduction of interfering peaks 
(Beckonert et al., 2007) whereas no general recommendations is present for LC-MS based 
metabolomics. However, for targeted lipidomics by LC-MS the used of EDTA is 
recommended to minimise loss of lysophospholipids (Seppanen-Laakso & Oresic, 2009). 
Both urine and plasma samples should be handled quickly and stored preferably at -80˚C, 
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where they can be kept for at least 9 months without significant changes in the metabolic 
profile (Beckonert et al., 2007). 
 
2.5.3 Sample preparation  
Sample workup before analysis depends on the type of sample being analysed, the analytical 
method and whether specific metabolites or all metabolites are of interest. For non-targeted 
LC-MS analysis of urine, no specific sample preparation (besides centrifugation) has to be 
employed, but dilution with water and/or filtration is a possibility to protect the LC-MS 
system. On the contrary, plasma contains a lot of proteins which will need removal before 
LC-MS metabolomics studies. Different plasma and serum deproteinisation methods in 
combination with LC-MS profiling were investigated by Want et al. (2006) and Bruce et al. 
(2008) who found that protein precipitation with respectively, 100% methanol and 80% 
methanol resulted in the highest number of metabolites and reproducibility. During 
establishment of the LC-MS metabolomics platform in our laboratory a high-throughput 
plasma deproteinisation method was further developed from the results of Bruce et al. (2008) 
and Want et al. (2006), and the procedure is presented in Gürdeniz et al. (2010) (see 
supplemental material). Regarding NMR-based metabolomics, no particular pre-treatment is 
necessary for plasma samples besides dilution with a deuterated lock solvent. Addition of the 
reference compound 3-trimethylsilylpropionic acid (TSP), which is normally used in 1H NMR 
experiments, is not recommended in plasma or other samples with high protein content due to 
protein binding and hereof much reduced signals (Beckonert et al., 2007). The natural 
occurrence of α-glucose was used as reference compound in Paper II as suggested by Pearce 
et al. (2008). In 1H NMR analysis of urine samples special concerns has to be focused on 
minimising the chemical shift due to difference in pH between the samples, and a buffer 
should be applied to the sample. Typically, a phosphate buffer in D2O and with TSP as a 
reference compound is used. Generally, samples should be kept cold while queued for 
analysis, and it is recommended to run one or two aliquots of a representative biofluid sample 
across the whole run as quality control measure (Beckonert et al., 2007).  
 
2.6 Analytical platforms  
The metabolome is dynamic, changing from second to second. Although the metabolome can 
be defined readily, it is not currently possible to analyse the entire range of metabolites by a 
single analytical method and multiple analytical platforms are needed to increase the coverage 
of the metabolome. LC-MS, GC-MS and 1H NMR spectroscopy are the most suited and 
commonly most used platforms for metabolomics studies (Oresic, 2009). LC-QTOF-MS 
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utilising electro spray ionisation (ESI) and NMR spectroscopy were the platforms selected in 
this research project. The basic principles of these two techniques are initially described, and 
their individual application for metabolomics are discussed at the end of this section.      
 
2.6.1 UPLC-QTOF-MS 
UPLC-QTOF-MS is a hyphenated technique, initially taking advantage of chromatography 
whereby it is possible to separate constituents of complex mixtures into single components 
(chromatographic peaks) and subsequently introduction of the fractionated eluate into a mass 
spectrometer for measurement of mass in relation to charge (m/z) of molecules and atoms. 
2.6.1.1 Ultra pressure Liquid Chromatography 
Chromatography in general is a very efficient separation technique, where molecules are 
separated by using small differences in their distribution in two-phase systems, consisting of a 
mobile and a stationary phase. Aqueous solutions of acetonitrile and methanol are the most 
common mobile phases, and molecules dissolved in the mobile phase are separated as the 
mobile phase passes through the stationary phase, depending on their distribution coefficient 
in the two phases. By reversed phase chromatography, which is the method applied in Paper I, 
separation mechanism depends on the hydrophobic interaction between the molecules in the 
mobile phase and the immobilised hydrophobic ligand in the stationary phase. Experimental 
conditions are designed initially to favour adsorption of the molecules from the mobile phase 
to the stationary phase and subsequently, the mobile phase composition is modified to favour 
desorption of the molecules from the stationary phase back into the mobile phase (Plumb et 
al., 2004;Poole, 2003).  
One of the primary drivers for the growth of the chromatographic technique has been the 
evolution of packing materials used to improve separation between peaks. Compared to the 
more classical high pressure liquid chromatography, the recently developed UPLC technology 
takes additional advantage of chromatographic principles in running separations by using 
columns packed with smaller particles and/or higher flow rates for increased speed, resulting 
in improved resolution and sensitivity (Plumb et al., 2004). 
 
2.6.1.2 Quadropole Time-of-Flight Mass Spectrometry 
The main features of a mass spectrometer consist of: an ion source, where the analytes are 
ionised and transferred to the high vacuum of the mass spectrometer; a mass analyser where 
ions are separated according to mass to charge ratio; a detector to measure the ion current 
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(amount of ions) or the ion number (by counting) as a function of time (Villas-Boas et al., 
2007). A QTOF mass spectrometer is illustrated in Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When the sample elutes from the chromatographic system, the sample is injected into the ion 
source where the molecules are converted to a charged or ionised form. Various different ion 
source techniques are used in metabolomics with the electro spray ionisation (ESI) being the 
most commonly used when coupled to liquid chromatography (Dettmer et al., 2007). ESI 
involves the passage of a solution through a needle held at high voltage relative to a counter 
electrode. The fine mist of droplets that emerge from the needle tip possess a net positive or 
negative charge determined by the polarity of the needle and are attracted to the entrance of a 
mass analyser (Villas-Boas et al., 2007).  
 
From the ion source the ions are guided into the mass analyser. The QTOF technology 
provides both a quadropole and time-of-flight mass analysers with an intermediate collision 
cell for possible fragmentation. A quadrupole mass analyser consists of four metal rods 
arranged in parallel where those opposite to one another are electrically connected by a radio 
frequency (RF) voltage supply. This creates an alternating electrical field between the rods. 
The charged molecules enter the quadrupole axially after they have been accelerated to a 
Figure 2: Schematic illustration of a Waters Q-TOF Premier with a single V reflectron flight path. From 
Waters (2005) with permission.   
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required linear energy. Once inside the quadrupole they start spinning within an imaginary 
cylinder created by the RF voltages. The diameter of the imaginary cylinder depends on the 
mass-to-charge ratio (m/z) of the ion and the RF voltage. Only ions within a certain m/z range 
will survive all the way through the quadrupole (Villas-Boas et al., 2007). In the study 
reported in Paper I the quadropole was operated as an ion filter, allowing the ions from 50-
1000 m/z to pass through the quadropole for accurate measurement by the TOF. The TOF is a 
high resolution MS instrument and functions by applying high voltage pulses to orthogonally 
accelerate ions into a high vacuum flight tube and a reflectron to reflect them back towards a 
detector. The mass-to-charge ratio is related to time-of-flight with smaller m/z’s reaching the 
detector first (Waters, 2005), and mass spectra can be created with a mass resolution up to 
10,000.       
 
2.6.1.3 Application of UPLC-QTOF-MS in metabolomics experiments 
The excellent sensitivity and high selectivity of a UPLC-QTOF-MS platform makes this 
instrument a great candidate for explorative metabolomics experiments of non-volatile 
compounds in a solution. The high resolution allows detection of metabolites of the same 
nominal mass but different monoisotopic mass, and, combined with a 5 ppm mass accuracy, 
the molecular formula can tentatively be determined of many metabolite peaks. The UPLC 
chromatographic separation minimises the overlap of peaks, which again improves mass 
accuracy, and additionally this method facilitates high-throughput analysis (e.g. 6 min/sample 
for the study in Paper I). The chromatographic separation provides very efficient knowledge 
of the polarity of an unknown molecule, and the elution time is an important characteristic in 
structure elucidation of unknown and/or isomeric compounds. 
 
A major issue and disadvantage encountered in ESI is what is known as matrix effects or ion 
suppression, and e.g. when analysing complex mixtures like urine and plasma, one analyte 
may be much more efficiently ionised than others (stealing more charge that expected from 
the concentration) resulting in suppression of other compounds. This will result in some types 
of compounds being quantitatively over estimated and others under estimated (Villas-Boas et 
al., 2007). Therefore, the best quantitative results may be observed by use of isotopically 
labelled reference metabolites for each metabolite in a targeted analysis, but this is not a 
usable approach for non-targeted profiling (Scalbert et al., 2009). Compared to triple 
quadropole MS, ion-trap-MS and NMR, the TOF-MS has a limited dynamic range and is 
therefore not suited for highly quantitative purposes.  
Analysis of the sample in both positive and negative ionisation mode will result in numerous 
overlapping analytes detected in the two modes but also a significant amount of unique 
compounds and it is highly recommended to do ionisation in both modes in non-targeted 
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analysis to obtain a broad coverage of the metabolome (Dettmer et al., 2007). Additionally, a 
minimum of two analytical replicates should be obtained when running ESI LC-MS 
metabolomics experiments, since the matrix effect may cause some slip in the detection of 
analytes.  
 
2.6.2 1H NMR spectroscopy 
2.6.2.1 Nuclear magnetic resonance spectroscopy 
High-resolution NMR spectroscopy is capable of providing detailed information on solution-
state molecular structures based on atom nuclear interactions and properties. The theory of 
NMR was initially proposed by Pauli  in 1924 who suggested that certain atomic nuclei 
should have the properties of spin and magnetic moment and that exposure to a magnetic field 
would consequently lead to the splitting of their energy levels (Pauli, 1924). However, it was 
first in 1946 that the NMR phenomena was experimentally discovered independently by 
Block & Packard (1946) and Purcell et al. (1946) and they were later awarded the Nobel price 
in physics 1952.  
Subatomic particles (electrons, protons and neutrons) can be considered as spinning on their 
axes. In atoms such as 12C and 16O, where the number of neutrons and protons are both even, 
these spins are paired against each other, such that the nucleus of the atom has no overall spin 
and cannot be detected by NMR. However, in some atoms, such as 1H and 13C, where the 
number of neutrons and/or the number of protons is odd, then the nucleus has a half-integer 
spin (i.e. 1/2, 3/2, 5/2), and the nucleus does possess an overall spin measurable by NMR 
(Lambert & Mazzola, 2004;Stryer, 1995). 
NMR spectroscopy functions by the application of strong magnetic fields and RF pulses to the 
nuclei of atoms. All nuclei are electrically charged, and any that have a spin generate a small 
magnetic field. When an external magnetic field is applied, an energy transfer is possible from 
the low-level to a high-energy level of the nuclei. The energy transfer takes place at a 
frequency that corresponds to the RF, and when the spin returns to its low-level state, energy 
is emitted at the same frequency. The signal that matches this energy transfer is measured in 
several different ways and processed in order to give an NMR spectrum for the nucleus 
concerned. The precise resonant frequency of the energy transition is dependent on the 
effective magnetic field at the nucleus, and this field is affected of shielding by electrons 
orbiting the nucleus. Consequently, nuclei in different chemical environments absorb energy 
at slightly different resonance frequencies, and this effect is referred to as the chemical shift. 
This also means that sample conditions, such as pH and ion strength, will affect the observed 
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NMR and in most cases only one analytical replicate is sufficient per time point (Beckonert et 
al., 2007).   
The major disadvantage of NMR spectroscopy, as compared to MS, is the low sensitivity and 
resolution of this technique. From this point NMR application is not a first-choice for 
explorative metabolomics analysis to identify new biomarkers. Thus, the development of 
instruments with higher magnetic field strength and cryogenically cooled probes has pushed 
the limits of detection (Keun, 2006), improving their use in non-targeted metabolomics. In 
this case the later spectral comparison demands that the spectrum acquisition and control of 
conditions should be very precise. Small changes in pH, temperature and presence of 
impurities or degradation of sample material should be minimised since these factors may 
lead to detection of false metabolic changes and hereby incorrect selection of potential 
biomarkers (Moco et al., 2007). 
The nature of NMR as a quantitative technique due to the number of nuclear spins is directly 
related to the intensity of the signal,makes a targeted metabolomics approach an evident 
option. Biofluid NMR analysis is also often done with a priori knowledge of what the data 
will reveal about a specific target. It would be expected that the response pattern of several 
analytes is reflective of a physiological change in e.g. disease status or dietary habits, and the 
comprehensive nature of an NMR metabolome data set may enable a global evaluation of the 
systemic response. This can be useful in itself but the pattern may also be searchable for 
specific analyte information that, solely or in combination, can provide new mechanistic 
relevance (Robertson, 2005).  
 
2.7 Data extraction and preprocessing 
The complexity and richness which are some of the key qualities of metabolomics data also 
makes data extraction and analysis very complicated. Since the metabolome changes from a 
dietary intervention may be rather discreet (e.g. compared to a medical intervention) data 
extraction errors will have a dramatic impact on the outcome of a study and therefore needs 
great attention. 
 
2.7.1 Data extraction of LC-QTOF-MS data 
Metabolomics raw data from MS systems are normally collected in centroid spectra or at least 
transformed to this format from continuous spectra as the first thing to reduce spectra 
 complexity before peak extraction. 
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The commercial software, MarkerlynxTM (Waters), was used in Paper I and it was found that 
different preprocessing parameters resulted in extraction of several non-identical features. As 
a compromise two different data sets, preprocessed with different parameters, were extracted 
and subsequently combined. Peters et al. investigated the impact of parameter selection in 
different software packages (MarkerlynxTM, MZmine and MetAlign) by used of spiked and 
non-spiked control samples to evaluated the number of retrieved spiked compounds together 
with the number of false positive (Peters et al., 2009). They recommended introduction of 
such samples in a metabolomics sample run for optimal parameter selection. Gürdeniz et al. 
(2010) found that data extracted by two different preprocessing approaches (MarkerLynxTM 
and in-house built extraction by Matlab) caused large differences in the rank of selected 
markers, but the majority of them were found by the two quite different preprocessing 
methods (Gürdeniz et al., 2010). This work also concluded that to achieve successful 
biomarker detection it is important to inspect the quality of the raw data (shift in mass and 
retention time) and preprocess according to its specific structure. 
 
2.7.2 Data extraction of NMR data 
NMR signals are collected as a function of time. The decaying signal that follows a pulse is 
called the free induction decay (FID). The chemical shift can be derived from the FID by 
utilising a Fourier transformation, whereby the time domain is converted into the frequency 
domain (Lambert & Mazzola, 2004). However, prior to Fourier transformation data is 
typically zerofilled and apodised to a certain line broadening. Hereafter, NMR spectra needs 
to be corrected for deviations from a flat horisontal baseline and phase errors. The employed 
NMR software can usually do this automatically but especially the phase errors may be more 
appropriately corrected by hand.  
Different factors (e.g. sample pH, temperature and minor instrumental drifts) may cause 
chemical shift variations, and the overall variation between samples needs to be compensated 
by a shift of the entire spectra by use of an internal reference compound. If this shifting is not 
sufficient a co-shifting algorithm can be applied (as in Paper II), whereby spectral alignment 
are performed in spectral intervals, hereby preserving the shape of the peaks. Additionally, 
before data analysis the residual water signal should be removed. 
 
2.7.2.1 Normalisation, centering and scaling of metabolomics data  
Data normalisation (scaling between samples) and scaling between variables is typically 
applied to remove unwanted systematic bias in ion or signal intensity measurements while 
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retaining the interesting biological information. The sources of obscuring variation may arise 
from inhomogeneity of samples, minor differences in sample preparation, instrumental 
pertubation and also data extraction steps may introduce an additional error (Sysi-Aho et al., 
2007). 
 
 
 
 
 
 
Each sample is usually normalised to unit sample intensity sum (as in Figure 5) or to unit 
sample vector length (Euclidean norm), since normalisation to a single or few selected 
variables will not be appropriate representatives for the chemically diverse metabolites profile 
present in these types of samples (Katajamaa & Oresic, 2007). However, these statistical 
normalisation approaches may not always be the most optimal procedure, since metabolite 
concentration increase in one group is not automatically balanced by a decrease of another 
group. A novel and very promising normalisation approach has been suggested by Sysi-Aho 
et al. (2007) utilising optimal assignment of multiple internal and/or external standards across 
multiple sample runs to help determine how the standards are correlated, which variation is 
specific to a particular standard, and which patterns of variation are shared between the 
measured metabolites and the standards. From this a mathematical model was developed to 
detect the systematic variation of metabolites as a function of variation of standard 
compounds. This advanced normalisation method was evaluated on LC-QTOF-MS 
metabolomics data, but the same strategy was considered applicable to other analytical 
platforms used in metabolomics as well.         
Before multivariate data analysis the data matrix is normally mean centered in order to focus 
on the difference between the samples rather than the direction of the overall variance. 
Centering converts all the concentrations to fluctuations around zero instead of around the 
mean of the metabolite concentration and hereby adjusts for offset variation between the high 
Figure 5. Chemical-shift referred (a) and co-shifted and normalised (b) 1H NMR spectra of 24 rat plasma 
samples. The peak (~1.27 ppm) refers to the CH2 groups of different lipids in lipoprotein particles  
a b 
28 
 
and low abundant metabolites (van den Berg et al., 2006). The addition of a scaling method 
should also be considered before data analysis in order to adjust for the fold difference 
between the detected metabolites. The most commonly used scaling methods for 
metabolomics data are autoscaling and pareto scaling. The first method employs the standard 
deviation as the scaling factor, whereas the square root of the standard deviation is the scaling 
factor for pareto scaling (van den Berg et al., 2006). It should always be considered that each 
type of data pretreatment emphasises different aspects of the experimental data, and each 
approach has both advantages and disadvantages. 
 
2.8 Data analysis  
Metabolomics data obtained from spectroscopy and spectrometry typically contains thousands 
of variables from each sample. Variables attained from NMR spectroscopy are normally 
highly correlated, whereas in mass spectrometry data, the individual variables are not directly 
correlated but hyphenated to a chromatographic dimension that sorts the variables by polarity, 
allowing some relation to the neighbouring variable.  
The multidimensionality of this type of data is difficult to comprehend and visualise, and 
invoke for analytical techniques which can extract the relevant information. Chemometric 
methods are here an obvious choice due to their ability to decompose complex multivariate 
data into simpler and potentially interpretable structures (Wold, 1987). Depending on the aim 
of the analysis, unsupervised or supervised methods may be applied and assist in e.g. 
obtaining an overview of data, in variable selection, in group classification or to relate the 
data set to a reference value for construction of prediction models. The following section aims 
at introducing the data analytical approaches applied in this project.  
 
2.8.1 Principal component analysis  
Principal component analysis (PCA) was first introduced in statistics by Pearson in 1901 
(Pearson, 1901) with a geometric interpretation of ‘lines and planes of closest fit to systems of 
point in space’, and Hotelling (1933) further developed PCA to its present stage. PCA can be 
generally described as a method that reveals the internal structure of a data set in a way which 
best explains the variance in the data. Mathematically a PCA model can be written as: 
X = T · P'+E  
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where X is the data matrix representing samples and variables decomposed into a score matrix 
(T) and a transposed loading matrix (P'). The E matrix contains the residuals, the part of the 
data not ‘explained’ by the principal component model. In this way, the score and loading 
matrix contains the systematic variation with respect to samples and variables, leaving the 
unsystematic variation in the residual (Wold, 1987). PCA offers a reduced dimensional model 
that summarises the major variation in the data into few axes, and in this way, systematic 
variation is captured in a model that can be used to quickly visualise which samples in the 
data set are similar or dissimilar to each other. From this, possible spectral loadings causing 
any treatment-related separation may be identified.  In Paper I, PCA was used as an initial 
explorative method to investigate to which extent the different treatments (apple and pectin) 
could be discriminated by the urinary metabolite profile. PCA was also used in a non-
metabolomics context in Paper III to obtain an overview of the variance structure of classical 
health related biomarkers and physiological data. Additionally, in both studies PCA was used 
to investigate for ‘outliers’, meaning inspection for highly deviating samples with respect to 
residual and hotelling values, but none such were detected.     
 
2.8.2 Partial least square regression 
The most commonly used chemometric method for quantification is partial least square (PLS) 
regression. This method is a very robust and powerful algorithm that can analyse data with 
numerous strongly correlated X-variables (e.g. spectra) and also simultaneously model one or 
several Y-variables (e.g. a response variable/biomarker) (Wold et al., 2001). This enables 
establishment of a linear model that can predict Y from the measured spectra in X. Like PCA, 
PLS regression generates a linear model of the data, but where PCA models the major 
variation in the data itself, PLS derives a model that describes the correlation between the X 
variables and a feature (Y variable) of interest (Keun, 2006). 
In Paper II, PLS regression was successfully applied in modelling of NMR spectra and 
cholesterol content in lipoprotein fractions from rat plasma samples. Cholesterol 
concentration in the main plasma lipoprotein fractions could hereby be predicted in unknown 
samples after NMR measurement (illustrated in Paper II and III). The development of these 
prediction models took advantage of the interval partial least square (iPLS) regression 
developed by Nørgaard et al. (2000), which is an extension of PLS regression. The iPLS 
regression model splits the NMR spectrum into a number of intervals, and PLS models are 
calculated towards the response variable for each interval. The predictive performance of the 
PLS model for each interval is compared with the predictive performance of the full spectrum 
model. The advantage of this approach is that the limited intervals contains less interference 
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from irrelevant parts of the spectrum and provides more precise and easier interpretable 
models with a comprehensive overview of which spectral regions are best correlated with the 
response variables. 
PLS is often used as a classification tool in metabolomics studies by applying the discriminant 
analysis approach (PLS-DA). For this analysis, a class vector is constructed of one variable of 
each class with a value of 1 if the sample belongs to a particular class and 0 if not. By 
regression against this class vector, latent variables can be derived that separate the classes 
from each other. This method has been applied to the data in Paper I (see Figure 6) but was 
not the final selected approach in the submitted manuscript. It seems worth mentioning that 
PLS-DA can suffer severely from overfitting, since the number of samples used in 
metabolomics applications is usually much smaller than the number of variables, and this can 
easily lead to chance classifications. Consequently, the PLS-DA algorithm can separate two 
groups comprised completely of random data, and focus on the validation process is 
particularly important in this analysis (Westerhuis et al., 2008).  
  
 
  
 
 
 
 
 
2.8.2.1 Validation 
Validation of chemometric models is a very central issue to ensure construction of reliable 
models and estimates of e.g. prediction error and to determine the optimal number of 
components. In this way, overfitting, meaning that the model classifies the training data well 
but future samples are classified poorly, may be avoided.  Cross validation may be applied 
Figure 6. PCA score plot illustrating control (●) and apple (▲) rat urine sample and PLS-DA loading plot with 4010 
metabolites detected by UPLC-QTOF-MS in negative ionization mode. The color intensity in the PLS-DA loading 
plot illustrate the variables correlation to a class vector. Data is autoscaled and validated by use of random 
segmented cross validation. Data from Paper I.  
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when the number of samples is limited, and all samples have to be used in the calibration 
model. By this approach the X data matrix is divided into a number of segments containing 
one or more samples (full or segmented cross validation, respectively). One by one the 
segments are left out, and the model is calibrated with the remaining sample and used to 
predict the samples in the omitted segment (Wold et al., 2001). Random segmented cross 
validation was used in Paper II for development of the PLS calibration models and to 
determine the optimal number of components to be used.  
As a stronger validation method, test set validation can be used when a study contains enough 
samples to be divided into a calibration set and a validation test set. Here, the calibration set is 
used to build the model, and the test set is subsequently applied to estimate the prediction 
error. Test set validation was used in Paper II, where the PLS calibration models was build 
from 40 samples, and an independent test set consisting of 20 samples was applied to the 
model to test the model performance in future predictions. The often used estimate of 
prediction error is the root mean square error (RMSE), which mimics the traditional standard 
deviation and is described in detail in Paper II.  
 
2.8.3 Variable selection 
In explorative metabolomics approaches the aim is typically to identify and select relevant 
variables from the chemometric methods described previously in this section. Especially 
supervised methods are used, where a priori knowledge is used to select variables that are 
considerably different between two different samples groups and may be new biomarker 
candidates when identified. The PLS-DA is one approach to select potential biomarkers, and 
this was initially used for biomarker selection in Paper I. Additionally, application of the 
multiple linear regression (MLR) model, forward stepwise selection (described in Paper I) 
was attempted on this data. Both methods resulted in the selection of a very high number of 
promising metabolites, but the identification process of these hundreds of metabolites seemed 
to be an unstructured and highly time-consuming task. Instead, a more biological and top-
down selection procedure was initiated, where variables were selected on the basis of their 
response behaviour and homogeneity between two classes (control and apple or control and 
pectin). The variables selected for identification were divided into exposure markers and 
effect markers, where exposure markers should have only zero values in the control group and 
positive responses in all animals in the comparing group. Effect markers were defined as 
markers that had a baseline response in all animals in one group and a significantly up- or 
down-regulated response in all animals in the comparing group. One misclassification was 
allowed in each group in order to tolerate small measurement errors of the MS 
instrumentation. Figure 7 illustrates the response pattern of what is classified as an exposure 
and effect marker. 
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This kind of variable selection may have particular suitability in studies with numerous very 
clear markers, as it can be found in animal studies, due to isogenetic animal strains and 
controllable dietary habits. In human intervention studies more pronounced inter-individual 
variation and diverging habits will most likely entail a more blurred response profile, and in 
this case this ‘exposure and effect marker’ approach may not be the optimal selection. 
Forward stepwise selection was also applied to identify a potential dose-response relationship 
between any of the urinary variables and the pectin intake (zero in the control group, 1 in the 
apple group and 16.5 in the pectin group).  This method selects variables in a stepwise manner 
based on their capability to improve an MLR model established between the chromatographic 
features and the pectin dose (described in more detail in Paper I). Due to the relatively high 
independence of variables in an LC-MS data set, the forward stepwise selection method may 
be well suited for this type of data. However, this method is also prone to overfit due to the 
low number of samples as compared to the number of variables, and careful validation is an 
important issue in this case.       
 
2.9 Metabolite identification 
Metabolite identification is an essential part of most metabolomics studies, but since this task 
is difficult and a time consuming step at the end of the metabolomics pipeline, it is sometimes 
ignored or left unfinished (Scalbert et al., 2009). Without compound identification no new or 
confirming metabolic information is gained, and the goal of a metabolomics study is not 
achieved.  
The effort required for identification of metabolites depends on the scope of the study, be it 
targeted or explorative. If the search is for known metabolites the identification involves 
[M-H
-
] 261.0079; rt 1.454 [M-H
-
] 191.0555; rt 0.641 
0.641.454 
Figure 7: Example of exposure (left) and effect (right) marker selected from urinary UPLC-QTOF-MS 
analysis. Control (×), pectin (□) and apple (+) samples. 
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comparing the experimental data with that of pure standards. If the metabolites can be 
predicted, then the metabolic identification involves finding representative standards and 
searching for the predicted metabolites. If nothing is known about the metabolites in the 
experimental data, as in explorative studies, the metabolite identification is much more 
complicated. This last approach is most widespread in MS metabolomics due to the high 
sensitivity and hereby the possibility to discover new and low-abundant metabolites. The 
explorative metabolite identification was investigated in Paper I and resulted in identification 
of metabolites linked to apple or pectin intake in rats. The identification strategy in this study 
took advantage of the accurate mass measurement and fragmentation pattern obtained from 
the QTOF instrument. The m/z value of the selected exposure and effect markers was 
searched in the Human Metabolome Data Base (HMDB). The database (version 2.5) contains 
over 7900 metabolite entries including both water-soluble and lipid soluble metabolites 
(Human Metabolome Database, 2010). If one or several metabolite hits matched the accurate 
mass of a searched metabolite, this was taken further in the identification process. The 
particular isotopic pattern in the mass spectra was inspected by use of the MarkerlynxTM 
elemental composition software, where particular the natural 13C abundance is taken into 
account. Then fragment ions in the raw data were considered by applying a mass fragment 
tool (MassFragmentTM, Waters) and finally an authentic standard of the proposed compounds 
was analysed by the UPLC-MS system to verify retention time and the fragmentation and/or 
adduct-forming pattern. 
However, several of the metabolites were left as tentatively identified, since the pure standard 
of these are not commercially available.  
 
NMR metabolite identification in this project has been limited to peak assignment from 
comparison of chemical shift with previous work (Paper II, Figure 2). However, the NMR 
technique can elucidate chemical structures and provide highly specific evidence for the 
identification of an unknown molecule, if they are at a high enough quantity  (Moco et al., 
2007). For most organic compounds in biological samples, the acquisition of one-dimensional 
1H NMR spectrum is not sufficient for full structure elucidation, and more advanced NMR 
measurements like homonuclear 1H-2D spectra or heteronuclear 2D spectra are very helpful 
for identification of unknown compounds (Dunn & Ellis, 2005). However, this task was 
beyond the scope of this project.  
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2.10 Biological interpretation 
When a metabolite has been identified, a relevant biological interpretation should be drawn 
related to the research question. Information about numerous biochemical pathways and 
metabolites interacting in these pathways is available in e.g. the KEGG pathway database 
(http://www.genome.jp/kegg/pathway) or the Nutritional Metabolomics Database 
(http://www.nugowiki.org). Additionally in the HMDB database most metabolites are 
described briefly in a ‘MetaboCard’ designed to contain chemical, clinical and biochemistry 
data. Besides these approaches the literature has to be thoroughly searched to put the 
identified metabolite into an appropriate biological context. When/if the identified metabolite 
is placed into a metabolic pathway this may lead to identification of additional unknown 
metabolites belonging to the same pathway, and the data set can be searched again now in a 
more targeted approach.  
Biological interpretation of urinary metabolites from apple and pectin intervention in rats is 
discussed in Paper I, just as the more classical biomarkers in relation to apple-powder, fresh 
apple and pectin intake are discussed in Paper II and III. The biological interpretation of all 
these biomarkers is jointly discussed in the ‘Results and Discussion’ section.  
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3 Potential disease prevention from apple intake 
 
Apple was selected as the nutritional case to be investigated during the establishment of our 
metabolomics platform. To enable biological interpretation of both well-established CVD risk 
markers and newly discovered metabolomics markers, some background knowledge of apple 
is needed. The following section describes the composition of apple, absorption and 
metabolism of presumed bioactive apple components as well as their physiological effects and 
site of action in relation to CVD. 
 
3.3 Composition of an apple 
Apples are primarily composed of water and carbohydrate with fructose accounting for the 
main part of the sugars and sucrose and glucose as minor parts. The macronutrient 
composition of an apple (the ‘Shampion’ cultivar) can be seen in Table 2 in Paper III. Apples 
contain several micronutrients as well with the most predominant being pro-vitamin A (β-
carotene), vitamin C and E, folic acid, magnesium and potassium (National Food Institute, 
2010). Apples contain normally >2 g fibre g 100 g-1 and different phenolic compounds (see 
Table 2, Paper III),  and in particular these two components are linked with potential health 
effects of apple intake (Cara et al., 1993;Nagasako-Akazome et al., 2005), for which reason 
their composition is further detailed in the following.          
 
3.3.1 Fibres in apples 
The fibre part can be divided into a soluble and an insoluble fraction. The insoluble fibres 
account for the major part and is made of cellulose, which consists of repeating monomers of 
glucose attached end to end. The cellulose framework is interpenetrated by a cross-linked 
matrix consisting of lignin, hemicelluloses, pectin and structural glycoproteins (Thakur et al., 
1997). Cellulose, lignin and to some extent hemicelluloses contribute to the insoluble fibre 
fraction of apple (Rani & Kawatra, 1994). Pectin is a highly hydrophilic polysaccharide that 
account for the majority of the soluble fibre fraction in apples. It has a complex structure and 
apple-pectin exhibits a high degree of esterification and has a very high content of branched 
side chains (Thakur et al., 1997) (see Figure 8).  
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3.3.2 Phytochemicals in apples 
Apples contain various phytochemicals, which are secondary plant metabolites and not 
considered as nutrients in mammals. The majority of these phytochemicals are phenolic 
compounds and only to a very limited extent phytosterols (Normen et al., 1999). As 
illustrated in Table 2, Paper III, the most predominant phenols are: procyanidins, which 
consist mainly of condensed (-)-epicatechin units and/or (+)-catechin; the flavanol 
epicatechin; the flavonol quercetin as glycoside and the phenolic acid chlorogenic acid. 
Epicatechin, quercetin and chlorogenic acid are shown in Figure 9-11. An intake of 2-3 apples 
a day may provide an intake of 100-150 mg/day of total phenolic compounds (calculated from 
Table 2, Paper III). 
The majority of polyphenols are present as glycosides and/or esters with exception of the 
catechins and proanthocyanidins. The concentration of these compounds may depend on 
many factors, such as cultivar of the apple, growth conditions, harvest time and storage of the 
apple (van der Sluis et al., 2001). The phenolic compounds are found in much higher 
concentrations in the peel than in the flesh. Quercetin conjugates are exclusively present in the 
peel, whereas chlorogenic acid tends to be higher in the flesh than in the peel (Escarpa & 
Gonzalez, 1998).       
 
 
Figure 8. Example of a branched pectin structure with a poly-α-(1-4)-D-galacturonic acid backbone with partial 
methylation, acetylation and four different types of branching. From Sigma Aldrich (2010). 
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3.4 Absorption, metabolism and mechanism of action of apple 
components 
3.4.1 Fibre 
3.4.1.1 Absorption and metabolism 
The water-insoluble fibre fraction in apples (cellulose, lignin and some hemicelluloses) is 
resistant to hydrolysis by the human digestive enzymes. Cellulose and hemicelluloses may to 
a limited extent be fermented by the microbiota in the colon, whereas lignin passes 
undegraded. Pectin, as the main soluble fibre fraction in apples, has high gelling properties 
and forms a viscous solution in the small intestine. Pectin is, like the insoluble fibres, resistant 
to hydrolysis by the human digestive enzymes but it is rapidly and completely fermented by 
the microbiota in the proximal part of colon. The end products of this fermentation are short 
chain fatty acids (SCFA) together with CO2, Ch4 and H2 (Spiller, 2001). The SCFAs are 
organic fatty acids with up to 6 carbon atoms with acetate, butyrate and propionate being 
produced at the in highest rate (Wong et al., 2006). Pectin seems to induce particularly high 
production of acetate (Schweizer & Edwards, 1992). SCFAs are very efficiently absorbed in 
caecum and colon by direct diffusion or cellular uptake involving Na+ and K+. Acetate is 
rapidly transported to the liver and to a lesser extent to the muscle cells, where it functions as 
fuel. Propionate functions as a primary substrate for hepatic gluconeogenesis, and butyrate 
serves as the preferred fuel of the colonic epithelial cells (Wong et al., 2006). 
   
3.4.1.2 Mechanism of action inducing physiological effects of apple fibre  
 
One of the most investigated physiological properties of soluble fibres is its ability to lower 
blood cholesterol. Several human and animal studies have been conducted with pectin 
supplementation from various sources, and most investigations find a significant reduction in 
Figure 9: (-)Epicatechin Figure 10: Quercetin Figure 11: Chlorogenic acid 
A 
B 
C 
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cholesterol (Judd & Truswell, 1982;KEYS et al., 1961;Stasse-Wolthuis et al., 1980;Sable-
Amplis et al., 1983b;Kay & Truswell, 1977) others find no effect (Aprikian et al., 
2003b;Sable-Amplis et al., 1983b;Schwab et al., 2006;Trautwein et al., 1998). There are 
typically two suggested mechanism whereby pectin may exhibit cholesterol an lowering 
effect. One suggested mechanism involves interference with lipid and/or bile acid 
metabolism. The gel-forming properties of pectin may bind bile acids plus cholesterol and 
prevent the (re)absorption in the small intestine (Kay & Truswell, 1977), leading to increased 
excretion of bile acids via faeces. As a consequence, hepatic conversion of cholesterol into 
bile acids will increase, hepatic pools of free cholesterol will decrease and endogenous 
cholesterol synthesis will increase. This is thought to increase activity of 7-α-hydroxylase and 
HMG-CoA reductase to compensate for the loss of bile acids and cholesterol from the liver 
stores. Furthermore, hepatic LDL cholesterol receptors become upregulated to restore the 
hepatic cholesterol pool, and this will lead to decreased serum LDL cholesterol concentrations 
(Theuwissen & Mensink, 2008) This is a proposed mechanism for water-soluble fibres in 
general, and Figure 12 gives an overview of this proposed regulation. 
 
 
 
 
 
 
The other suggested mechanism whereby pectin may exhibit a cholesterol-lowering effect 
links to effects of the SCFA produced by fermentation of microbiota in the colon. Propionate 
Figure 12: A proposed cholesterol lowering mechanism of water-soluble fibres like pectin. The soluble 
fibers form a gel in the intestinal lumen, whereby (re)absorption of cholesterol and bile acids may be 
decreased. This leads to an increased faecal output of these two components. As a result hepatic 
conversion of cholesterol into bile acids increases, hepatic pools of free cholesterol decrease and 
endogenous cholesterol synthesis increases. In addition, hepatic LDL cholesterol receptors are up-
regulated to re-establish hepatic free cholesterol stores. These processes will ultimately lead to 
decreased serum LDL cholesterol concentrations (from (Theuwissen & Mensink, 2008). 
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has been reported to inhibit cholesterol synthesis in the liver (Rodwell et al., 1976;Venter et 
al., 1990), and this is the main argument in the SCFA-cholesterol lowering theory. However, 
consensus is not established in this area. Propionate is at the same time found as a substrate 
for hepatic gluconeogenesis and in this way it seems to have two opposite and competing 
effects on the gluconeogenesis (Wong et al., 2006). Acetate is hypothesised as a primary 
substrate for cholesterol synthesis. Wolever et al. (1989) studied the effect of rectal infusion 
of SCFA on lipid metabolism, and subjects given infusion of two doses of a mixture of 
acetate and propionate (90:30 nmol and 180:60 nmol) showed a dose-dependent increase in 
serum total cholesterol and triglyceride level. Another study by the same research group 
showed that acetate infused alone (180 nmol) produced a significant rise in total and LDL 
cholesterol (Wolever et al., 1991). The authors concluded that these findings revealed indirect 
evidence that SCFA is utilised in lipid synthesis and that the exact effect of SCFA may 
depend on the ratio of propionate and acetate.  The infusion method used in these studies can 
be debated, since the dosage rate may not simulate that of the SCFA produced by the colonic 
microbiota, and in general the effects of SCFA in cholesterol metabolism may still be 
regarded as unclear.  
No cholesterol-lowering effects have been seen by cellulose and hemi-cellulose directly, but 
since these fibres are fermented to some extent, the resultant SCFAs may also have a certain 
impact with respect to this proposed mechanism. However, the insoluble fibre fraction is 
primarily regarded as being responsible for an increased stool bulk and helping to regulate 
bowel movements.  
 
3.4.2 Phenolics and polyphenols  
3.4.2.1 Absorption and metabolism 
Various factors have an impact on the bioavailability of polyphenols. As stated earlier, the 
majority of polyphenols are present as glycosides in the apple, and this influences absorption 
in the gut. The bioavailability and metabolism of the most predominant apple phenolics are 
detailed here. 
Procyanidins: Procyanidins are found as the B2 dimer (epicatechin-(4β-8)-epicatechin) in 
apple (INRA, 2010). The high molecular weight of procyanidins seems to hinder the intestinal 
absorption (Donovan et al., 2002), and they pass unaltered into the colon where they can be 
catabolised by the gut microbiota. Appeldoorn et al. (2009) conducted an in vitro 
fermentation of different purified procyandins (also the B2 dimer) with human microbiota and 
found 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-γ-valerolactone as the 
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main metabolites. Bioavailability and metabolism have not yet been investigated with pure 
procyanidins in humans, but in accordance with Appeldoorn et al., we tentitatively identified 
dihydroxyphenyl-γ-valerolactone as a urinary marker from apple supplemented rats (Paper I). 
5-(3,4-dihydroxyphenyl)-γ-valerolactone was also identified by Li et al. (2000) as a major 
human urinary metabolite after intake of (-)-epicatechin, and some extent of microbial 
breakdown of procyanidins to monomer (-)epicatechin and further to 5-(3,4-
dihydroxyphenyl)-γ-valerolactone seems plausible.  
Catechins: Especially (-)epicatechin, but also its isomer (+)catechin, is prevalent in apples to 
some extent. These catechins are believed to have a relatively high bioavailability and can be 
absorbed directly in the small intestine. The absorbtion and metabolism of catechin was 
investigated by (Donovan et al., 2001) via an in situ model of small intestinal perfusion in 
living rats, and absorption and metabolism of epicatechin are believed to proceed in the same 
way. These authors suggested that catechin enters the enterocytes by passive diffusion, and 
here they are primarily glucuronidated and/or to a lesser extent methylated. From the 
enterocytes the conjugated catechins are transported to the liver, where further re-/de-
glucuronidation/methylation or sulphation can occur. The glucuronated and methylated forms, 
are the circulating forms whereas the glucuronated+sulphated forms primarily are thought to 
be eliminated by bile (Figure 13). The formation of sulphate, glucuronide and/or methylated 
metabolites occur through the respective action of sulfotransferase (SULT), uridine-5´-
diphosphate glucuronosyltransferases (UGTs) and catechol-O-methyltransferases (COMT) 
(Crozier et al., 2009).  
 
 
 
 
Natsume et al. (2003) has elucidated the chemical structure of (-)-epicatechin metabolites in 
human and rat urine after oral administration of this compound, and the major circulating 
Figure 13: A schematic representation of the possible mechanisms of absorption and metabolism of catechin 
in rats. Abb.: 3´OMC, 3´-O-methylcatechin (From Donovan et al. (2001). 
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metabolites in humans were found as: epicatechin-3'-O-glucuronide, 4'-O-methylepicatechin-
3'-O-glucuronide, 4'-O-methylepicatechin-5- or 7-O-glucuronide, and in rats: epicatechin-3'-
O-glucuronide, epicatechin-7-O-glucuronide and 3'-O-methyl-epicatechin-7-O-glucuronide. 
The aglycones epicatechin was also found in both humans and rats. The authors stated that the 
difference in catechin metabolism between humans and rats was that the glucuronidation of 
epicatechin occurs at the 7 position of the A ring for rats and at the 3´position of the B ring in 
humans. 
(-)Epicatechin was identified as a urinary exposure marker from apple intake in Paper I, and 
the epicatechin glucuronide, methylated epicatechin and catechin glucuronide were also 
recognised, although only tentitatively identified, because lack of authentical standards 
hindered confirmation of retention time for these compounds. 
Quercetin: Quercetin is primarily found as quercetin-3-glycoside, rutinoside, rhamnosides, 
xylosides and galactosides in apple (Boyer & Liu, 2004;INRA, 2010). Some glycosides are 
able to be absorbed in the small intestine, and there are two possible routes by which 
glucoside conjugate can be hydrolysed and the resultant aglycones can be formed in the 
epithelial cells. One possibility is that the glycoside is hydrolised by lactase phloridizin 
hydrolase (LPH) in the brush-border of the small intestine epithelial cells and hereafter enters 
the cell as aglycone by passive diffusion. Alternatively, the intact glycoside conjugate may be 
transported into the epithelial cells by the sodium-dependent glucose transporter SGLT1, 
where after cytosolic β-glucosidase can mediate hydrolysis (Crozier et al., 2009). Quercetin-
3-glycoside is thought to utilise the LPH, whereas the quercetin rutinoside, rhamnosides, 
xylosides and galactosides are not easily hydrolysed, and most likely pass unchanged through 
the small intestine and may be degraded/hydrolysed by the microbiota in colon (Boyer & Liu, 
2004). Like the catechins, quercetin is subjected to glucuronidation, sulphation and/or 
methylation before passage into the blood stream and further phase II metabolism occurring in 
the liver by hepatocytes, which contain b-glucuronidase activity (Mullen et al., 2006). Some 
of the quercetin conjugates may be recycled back into the intestine via the bile, but most will 
be excreted in urine (Crozier et al., 2009).  
Chlorogenic acid: Only very small amounts of chlorogenic acid are believed to be absorbed 
intact in the intestine, and the majority appears to be metabolised by the gut microbiota in the 
colon (Gonthier et al., 2003). Gonthier et al. (2003) found that rats supplemented with 
chlorogenic acid primary increased excretion of hippuric acid and m-coumaric acid. Quinic 
acid is also a known microbial metabolite of chlorogenic acid, and this metabolite was found 
as an apple exposure marker in Paper I. However, quinic acid is also naturally present in 
apples and the origin of this phenol may not only derive from chlorogenic acid.    
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3.4.2.2 Mechanism of action inducing physiological effects of apple polyphenols  
 
The interest in health effects of dietary polyphenols have primarily been driven from 
epidemiological studies that indicate an inverse relationship between intake of polyphenol 
rich foods and different diseases such as CVD, diabetes and cancers. Based on this numerous 
in vitro studies have been performed with the aglycone form of polyphenols showing 
promising disease preventive effects of these compounds. However, most circulating 
polyphenols are glucuronidated, methylated and/or sulphated but there are only limited 
studies elaborating on the biological properties of the conjugated derivatives (Crozier et al., 
2009). The lack of commercially available compounds complicates improvements in this area. 
Studies where the biologically relevant substances are used to investigate mode of action in 
relation to health effects (or CVD risk) are considered in the following. 
Procyanidins: Since the procyanidins are not absorbed, they do not exhibit a direct systemic 
response but during their passage in the intestine they may exert some effects through 
interactions with other components, such as lipids. However, a potential health effect of these 
structures may most likely be attributable not to direct actions of procyanidins themselves but 
to actions of some of their microbial metabolites that can be more readily absorbed. Only very 
limited investigations have been conducted with the presumed procyanidin metabolite, 5-(3,4-
dihydroxyphenyl)-γ-valerolactone. (Li et al., 2000) suggested antioxidative activities of this 
compound based on the chemical structure (Figure 14), and a study by Unno et al. (2003) 
found that 5-(3´,4´-dihydroxyphenyl)-γ-valerolactone had stronger antioxidant potential than 
vitamin C in vitro, but no studies have been performed elaborating on the biological effects of 
this compound in vivo.  
 
 
 
 
 
Catechins: A study by Spencer et al. (2001) compared the epicatechin aglycone with  3’-O-
methylepicatechin and epicatechin glucuronides (epicatechin-7- and epicatechin-5-O-β-D-
glucuronides) regarding the ability to protect against oxidative stress of primary cultures of 
neurones. They found that the epicatechin glucuronides were not able to protect against 
oxidative stress as it was the case for the native form of epicatechin and 3’-O-
methylepicatechin. Cren-Olive et al. (2003)  studied the ability of 3'-O-methylcatechin and 4'-
Figure 14:. 5-(3,4-dihydroxyphenyl)-γ-valerolactone from Li et al. (2000) 
43 
 
O-methylcatechin to protect LDL from in vitro oxidation  and found these metabolites less 
efficient in protection than catechin. The authors concluded that their results did not support a 
direct physiological relevance of catechins as antioxidants in lipid processes. No animal or 
human studies have been conducted with an isolated epicatechin or catechin supplement to 
elaborate on health effects of these compounds. 
 
Quercetin: Kawai et al. (2008) developed a monoclonal antibody targeting the quercetin-3-O-
glucoronide in humans and demonstrated the target sites of the metabolite that specifically 
accumulates in macrophage-derived foam cells in atherosclerotic lesions in human arteries. At 
this location the quercetin conjugate was found to be converted to the aglucone quercetin that 
subsequently reduced the lesion size. Manach et al. (2004) have reported on, the existence of 
intermolecular bonds between serum albumin and quercetin conjugates in the blood stream, 
and this mechanism slows the elimination of quercetin fra the body, whereby a prolonged 
systemic effect is possible. The reported half-life of quercetin ranges from 11 to 28 hours, 
whereas it appears shorter for catechins (3-8 hours) (Manach et al., 2005). 
 
Generally, the evidence of potential disease preventive mechanism of apple polyphenols is 
very limited, and more in vitro investigation, and in particular in vivo, are needed to reveal 
health effects of these substances.   
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4 Results and Discussion 
This section initiates with methodological considerations of the research that is the basis for 
Paper I, II and III in this project. The reader is referred to the individual papers for a detailed 
survey of the results, and the aim of this section is to link together the results of Paper I-III 
and to consider aspects and reflections that did not found their way into the papers.  
 
4.1 Methodological consideration 
4.1.1 Study design 
This project deals with four different animal experiments, whereof two were used purely to 
build NMR-based PLS calibration models (Paper II), and these models were utilised to predict 
cholesterol in different lipoprotein fractions in two other rat studies; one with different doses 
of apple-powder (Paper II) and one where fresh apple and apple-pectin were used as 
supplements (Paper I and III).  
The animal study used for Paper I and III has some limitations in its study design, especially 
with regard to its use in the explorative metabolomics approach (Paper I). The study had a 
parallel design, but the isogenic nature of the animals, as compared to humans, may justify the 
choice of design to some extent. However, our attempt to detect pectin dose response markers 
would have benefitted from a cross-over design whereby the exact individual response for 
each dose level could have been measured for each rat. Additionally, inclusion of more 
animals (n=24) in the studies would have aided in the data analysis and interpretation of this 
study.  
4.1.2 Rat studies and extrapolation to humans 
The use of animal studies has its peculiarities and limitations as compared to human studies. 
The rats selected for these studies have a relatively standardised genotype, and their habits are 
more controllable compared to humans. This will induce a lower level of variation and make 
potential biological effects or metabolome biomarkers clearer. However, the genetic 
differences between rats and humans may result in some effects and physiological responses 
that are completely ignored, because the rat is insufficiently sensitive to the specific treatment.  
Rats have a higher metabolism rate than humans, and there will be some deviation in 
metabolism, e.g. they seem to methylate dietary phenols far more extensively than humans 
(Crozier et al., 2009). Regarding cholesterol metabolism, the rats are deficiency in cholesterol 
ester transfer protein (CETP) (Ha & Barter, 1982), and the major part of cholesterol is carried 
in the HDL particles in contrast to humans where LDL particles carry most cholesterol. These 
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factors clearly state that there are many cautions to be taken when extrapolating data from 
animal to humans. However, investigation of organs, such as the liver and intestine is not 
possible in humans to the same extent as in rats, and the experimental conditions can be much 
more controlled. These aspects make animal models suited to study mechanisms of action but 
confirming experiments in humans is always recommended.   
 
4.1.3 Considerations with regard to selected markers  
In Paper I the markers were selected depending on their MS intensity response pattern as 
either effect or exposure markers. The effect markers should ideally be an expression of 
changes in the endogenous metabolome or the microbial metabolome of the host induced by 
e.g. apple intake. Identification of the specific metabolite can provide insight into metabolic 
pathways that are affected by apple intake, and this may generate new knowledge of the site 
of action for a potential health effect of apples. This will generate several new questions and 
highlight new places to search for mechanistic answers. However, the effect marker response 
may also derive from the food metabolome and illustrate imbalances in the standard feed 
between the groups. Quantitative measurements of identified effect markers could further 
improve the interpretation of a biological effect.  
Exposure markers are ideally an expression of changes in the xenometabolome, which 
correspond to compounds not used in the energy metabolism. Identification of these 
metabolites can imform about compounds that the organism has been exposed to and how 
these have been metabolised (at least the last step) before they are excreted. From previously 
conducted studies it is possible to elaborate on potential health effects from exposure of the 
specific compound, but the key quality of this type of markers is that they may later be used 
as biomarkers of the specific food item. Thus, this will involve quantitative analysis and the 
specific marker should be validated for uniqueness in the food item/group and subsequently in 
dose-response investigations. The rat study in Paper I uncovered numerous exposure markers, 
and it would not be expected to find a similar result in a human intervention study. The 
collection of these markers may be used to unravel the presumed more blurred response 
behaviour of markers in human studies investigating apple or even fruit-related interventions. 
Despite the metabolic differences between rats and humans, it is thought possible to identify 
some of the apple and pectin related markers in humans as well, and potentially these could be 
combined selectively by multivariate modeling to search for associations between response 
patterns and dietary intake. An apple, pectin or fruit exposure or intake biomarker, 
considering several metabolites at the same time, could hereby be developed. 
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Several more classical health related biomarkers were measured in the rat study used for non-
targeted metabolomics and they were reported in Paper III. A PCA was constructed with these 
markers to give an overview of the rats response variation in the different markers (Figure 3, 
Paper III). The traditional biomarkers and physiological data could be combined with e.g. the 
metabolome effect markers in a PCA (autoscaled data), and potential co-variance between 
these two types of markers could be identified as markers with nearby location in the 
multivariate space. This could highlight metabolomics markers of particular interest and 
obvious candidates for identification. After identification, a causal biological connection 
between the traditional marker and the metabolome marker may be verified. 
 
4.2 Evaluation of effects of apple and pectin intake 
4.2.1 Effect of fresh and dried apple and pectin on cholesterol metabolism markers 
4.2.1.1 Apple and cholesterol metabolism 
The main findings in relation to cholesterol distribution in the different lipoprotein fractions 
in Paper II and III showed that rat feeding with a moderate amount of fresh apple during 4 
weeks reduced total, HDL and LDL cholesterol compared to the control group, whereas a 
10% and 20% apple-powder dose only showed significant reduction of HDL cholesterol for 
the high dose. The amount of apple used in these studies can be estimated to correspond to a 
human intake of 3-4 apples/day for the fresh apple, and the 10% apple-powder dose 
corresponds to the same amount. Considerable evidence has shown a clear association 
between decreased total and LDL cholesterol and reduced risk of CVD (Briel et al., 2009), 
and based on this, intake of fresh apples seems to be favourable to improve cardiovascular 
health. The explanation of why the same effect is not found in apple-powder supplemented 
rats may most likely relate to the formulation of the apple supplement or the standard feed, 
since these rats were the same age, same strain and kept at the same conditions. The standard 
feed differed slightly between the studies, since fructose and sucrose were balanced in the 
apple-powder study and not in the fresh apple study.  The finding of non-significantly 
elevated VLDL cholesterol and triacylglyceride TAG in the fresh apple group compared to 
the control could be caused by the high fructose content in apples. When fructose is consumed 
it will enter the hepatic glycolytic pathway, and in contrast to glucose metabolism, fructose 
can serve as an unregulated source of both glycerol-3-phosphate and acetyl-CoA, facilitating 
enhanced VLDL and triglyceride production in the liver (Havel, 2005). However, TAG was 
not measured in the apple-powder study, and VLDL appeared to rise in the 20% apple-powder 
group in the same way as seen in the fresh apple study, indicating that the fructose balancing 
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difference does not give a straightforward clarification on the divergences between the two 
studies.  The formulation of the apple supplement, dried and grounded apple-powder versus 
fresh apple, is most likely the cause of the different results between the studies.   
Just as a high total and LDL cholesterol have been declared as independent risk markers of 
CVD in humans, so has a low HDL (Grundy et al., 2004). The significant decrease of HDL 
cholesterol observed in both Paper II and III seems surprising, since we expected a rise in 
HDL, when LDL and total cholesterol were decreased. This may be brushed aside as a 
coincidence or due to the rats CETP deficiency and the different distribution of cholesterol 
between HDL and LDL as compared to humans, however, from the literature (human and rat 
studies) it seems striking that a lowering in total and LDL cholesterol is not always 
accompanied with an increase in HDL cholesterol (Ohashi et al., 2005;Aprikian et al., 
2001;Briel et al., 2009), and a more varied view on cholesterol metabolism may be needed. A 
study by Ohashi et al. (2005) has shown that very low HDL cholesterol levels can be present 
in rodents, where atherosclerosis is markedly reduced. This result was explained by hepatic 
over-expression of the scavenger receptor (SR-BI) in the reverse cholesterol transport (RCT) 
pathway. The RCT pathway delivers free cholesterol from macrophages or other cells to the 
liver or intestine. Major constituents of the RCT pathway include acceptors, such as HDL and 
apolipoprotein A-I, and enzymes, such as lecithin cholesterol acyltransferase and CETP, 
which regulate cholesterol transport. Introduction of exogenous active compounds, e.g. from 
apple in rats as well as in humans, may induce or decrease activity and production of enzyme, 
transporters and receptors acting in the RCT pathway. Lewis & Rader (2005) stated that the 
flux of cholesterol through the RCT pathway may be a more important determinant of 
cardiovascular disease risk than steady-state HDL cholesterol concentrations. The HDL 
cholesterol-lowering effect we observed from the apple treatment may be due to increased 
activity of players in the RCT pathway, which thereby might cause a higher throughput and 
lower net cholesterol concentrations in HDL particles. Additionally, in this investigation 
(Paper II and III), we only measured the main lipoprotein fractions, and since what is 
classified as a fraction (e.g. HDL) spans over several sub-fractions with dynamic change in 
size and density, this has to be taken into account as well. There is substantial evidence that 
different HDL sub-fractions have differing functional properties (Ansell, 2007;Briel et al., 
2009), and their varying effects most likely affect their relation to cardiovascular protection. 
Therefore, indiscriminate evaluation of the main HDL fraction as ‘good’ or ‘bad’ does not 
seem reliable and future studies should evaluate the risk related to HDL by considering 
subfractions as well. The targeted metabolomics approach applying NMR spectroscopy and 
PLS modelling could here serve as an elegant and time-saving alternative to the troublesome 
separation of subfractions by ultracentrifugation. 
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4.2.1.2 Pectin and cholesterol metabolism 
An apple-pectin supplement was introduced in the study in Paper III, and this facilitates 
interpretation of pectin as a cholesterol decreasing component of apple as proposed by the two 
cholesterol-lowering mechanisms stated in chapter 3.2.1.2. Pectin was not found to exhibit a 
lowering effect on total and LDL cholesterol and did not significantly increase the total faecal 
bile acids excretion. This finding was supported in the study by Aprikian et al. (2003), who 
also found no effect of apple-pectin on total plasma cholesterol. However, these authors found 
that hepatic cholesterol significantly decreased and faecal neutral sterol excretion significantly 
increased by the pectin treatment. From this result it seems likely that apple-pectin may 
enhance neutral sterol excretion (cholesterol and different metabolites hereof) to a higher 
degree than bile acid excretion. This is confirmed by an earlier study (Gonzalez et al., 1998), 
where apple-pectin was shown to increase cholesterol in faeces. Investigation of hepatic 
cholesterol and neutral sterol excretion was unfortunately not examined in the Paper III 
investigation, and these aspects would have strengthened our understanding of pectins 
influence on cholesterol metabolism in this study.  
A high dose of apple-pectin was used in our investigation and since pectin seems to 
particularly induce production of acetate (Schweizer & Edwards, 1992), this may to some 
extend explain why LDL and total cholesterol are not decreased to the same extent in the 
pectin group as in the apple group. As stated in chapter 3.2.1.2, acetate may be a substrate for 
cholesterol synthesis and hereby cause a higher total and LDL cholesterol in the pectin group.  
4.2.1.3 Pectin as an isolated apple component   
From our investigations pectin does not seem to be the main cause of a plasma cholesterol-
lowering effect of apple, but it may still be one of the active players in inducing this effect. 
Performing nutritional experiments with purified components may not always be comparable 
to how these components are and act when they are in their original matrix. Apple-pectin is 
typically extracted from dried apple pomace, and the native pectin is made soluble through 
heated acid extraction. After this, the pectin is precipitated with alcohol from the aqueous 
phase and dried (Obi-Pectin AG, 2010;Thakur et al., 1997). These procedures will 
undoubtably introduce some deviating characteristics of pectin as compared to their structure 
in the fruit, and pectin may potentially lose its 3 dimensional structure during processing. 
Furthermore, one of the pectin markers identified in the metabolomics analysis in Paper I (2-
furoylglycine) indicates that the cleaning procedure may give rise to furan derivatives. In 
Paper III we reported a significant increase in plasma alkaline phosphatase in the pectin 
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group, indicating that some adverse health effects may be caused by the high pectin dose, and 
the furan derivative may be speculated to partially cause this effect.   
Compounds occurring naturally in the apple may even trail pectin through the purification 
procedure, and a urinary metabolite from the study in Paper I (pyrrole-2-carboxcylic acid) 
indicates a high intake of hydroxyproline in the pectin group. Apple fruit tissue has a high 
content of readily soluble glycoproteins, rich in hydroxyproline, and (Knee, 1973) found this 
amino acid still present in the pectin fraction after the purification process. Therefore, when 
introducing isolated components in interventions, the knowledge of purity and comparability 
of the component in the source material is a crucial factor in interpretation of results and 
involved mechanisms. Specific for pectin, is remains questionable if it is at all possible to 
isolate and use this component and obtain results that are comparable to the component 
embedded in the whole food matrix.  
 
4.2.2 Metabolomics exposure and effect markers of fresh apple and pectin intake 
4.2.2.1 Apple exposure and effect markers 
Epicatechin, one of the main polyphenols in apples was, not surprisingly, detected as a urinary 
exposure marker of this fruit (Paper I). The epicatechin glucuronide, methylated epicatechin 
and catechin glucuronide were also recognised, although only tentitatively identified, and 
illustrates the phase II metabolism of the parent compound. Only limited research has been 
conducted to clarify potential health effects of these compounds (Crozier et al., 2009;Manach 
et al., 2004), and it seems likely that the mammalian phase II enzymatic protection 
mechanism neutralises most health beneficial effects of catechins by glucuronidation. The 
compound dihydroxyphenyl-γ-valerolactone was also tentitatively identified and is possibly a 
microbial metabolite originating from both procyanidin and epicatechin. This metabolite and 
the epicatechin aglycone may more likely be contributors to the health effects of apple that we 
observed in Paper III, especially in regard to the increased hepatic gene expression related to 
glutathione synthesis as well as glutathione utilisation that potentially demonstrate a higher 
ability to handle oxidative stress in the apple fed rats.  
Since apple contains a relatively high levle of quercetin glycosides some metabolites with this 
origin was expected, but none were found. Quercetin conjugates are exclusively present in the 
peel, and since all rats did not have the same preference for the eating the apple peel (as stated 
in Paper III), this may have caused an uneven quercetin exposure among the animals. The 
procedure for marker selection based on a consistent response among all rats in a group and 
was not able to select such markers.   
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Several markers were identified that very likely have their origin from chlorogenic acid 
(quinic acid, m-coumaric acid, hippuric acid and potentially 3-hydroxyhippuric acid). 
Hippuric acid and 3-hydroxyhippuric acid were present as effect markers (high response in 
the apple group and low response in the control group), and this may indicate a higher 
efficacy of specific metabolic pathways of the gut microbiota and glycine conjugation system 
in liver and kidney. An effect on the composition and efficacy of the gut microbiota in the 
present study is therefore indicated and is in accordance with previously published findings 
from this study, where apple intake was shown to affect caecal microbial composition by 
applying a PCA to data from denaturing gradient gel electrophoresis profiles of 34 different 
bacteria strains (Licht et al., 2010).  
 
4.2.2.2 Pectin exposure and effect markers 
Pectin is thought to be completely fermented by the intestinal microbiota and the resulting 
SCFA primarily used as fuel in different compartments of the organism. Consequently, it was 
not expected to discover any pectin exposure markers in our metabolomics analysis, except 
potential residues of SCFA and metabolites hereof. However, 39 pectin exposure markers 
were detected, whereof two were identified (pyrrole-2-carboxylic and 2-furoylglycine). These 
two markers emphasise the influence of the pectin purification method and how this may 
affect what we at first think is completely comparable with the unisolated component in the 
original material. This highlights the value of the non-targeted and hypothesis-free 
metabolomics approach; it promotes new and unexpected findings that may be helpful in 
interpretation of results from a specific intervention.  
 
4.2.2.2 Catecholamine metabolism 
Several apple and pectin effect markers were tentatively identified, and four of these seemed 
to be catecholamine metabolites that may describe changes in the hormonal metabolism after 
the apple and pectin diet. In the apple group 3-methoxy-4-hydroxyphenylethyleneglycol 
sulphate was increased compared to the control group. This compound is the major metabolite 
of norepinephrine (Goldstein et al., 2003), and to support our identification a fragment ion 
with a mass of 165.0557 m/z was found, and it seems likely to be the unconjugated parent ion 
(loss of the sulphate group, SO3-). Homovanillic acid sulphate, as another catecholamine 
metabolite that originates from L-dopa, was also tentatively identified as an effect marker that 
increased in the apple group. Metanephrine, which is a catechol O-methyltransferase 
derivative of epinephrine (adrenalin), was found to decrease in the apple group compared to 
the control group. Additionally, in the pectin group we found an upregulation of 
hydroxyphenylacetylglycine and methoxytyrosine, which are both metabolites that originate 
from L-dopa (Goldstein et al., 2003). Several different enzymes are active in catecholamine 
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metabolism, and it seems likely that these are affected in different ways by circulating 
bioactive components from apple and pectin intake. It may cautiously be hypothesised that the 
physiological response to apple-pectin intake (from fresh apple and purified) especially 
affects gene(s) or enzyme(s) related to conversion of L-dopa and norepinephrine, and other 
apple components affect gene or enzyme systems related to liberation of metanephrine and 
epinephrine. Both norepinephrine and epinephrine have been subject to substantial research 
attempting to establish a link between various health disorders and the catecholaminerigic 
system, but their mechanisms of action are still highly debated Kasparov & Teschemacher 
(2008). Special focus has been on the function of the cardiovascular system, and drugs that 
interact with norepinephrine and epinephrine receptors are widely used in cardiovascular 
medicine (Kasparov & Teschemacher, 2008).        
4.2.2.3 Cholesterol metabolism 
The tentatively identified apple effect marker, 3-methylglutaconic acid, seems very interesting 
with regard to the total and LDL cholesterol lowering effect of apple (Paper III). 3-
Methylglutaconic acid is an intermediate metabolite in the mevalonate shunt, the isoprenoid 
biosynthetic pathway that appears to participate in the regulation of cholesterol synthesis 
(Marinier et al., 1987). Mevalonate is the direct product of the rate-limiting step in cholesterol 
synthesis, which is catalysed by HMG CoA reductase and 3-methylglutaconic acid is 
produced in a co-pathway to the mevalonate-cholesterol pathway (Pappu et al., 2002). The 
down-regulation of 3-methylglutaconic acid in the apple group is in concordance with the 
high, although non-significant, decrease in the hmgcr gene expression described for these rats 
in Paper III, and it is expected that also mevalonate is downregulated with reduced cholesterol 
synthesis as a consequence. If these findings hide the truth there are some divergences with 
our discovery of increased total bile acid excretion in the apple group (Paper III), since this is 
thought to induce increased cholesterol synthesis. We did not find 3-methylglutaconic acid or 
other directly related cholesterol markers being up- or down-regulated in the pectin group, 
and it appears to be other bioactive components or factors than pectin that are responsible for 
a potential reduction in cholesterol synthesis. In general, the reduction of plasma cholesterol 
by apple seems more complex than that illustrated by generally known mechanisms, and it 
seems evident that more/other players in cholesterol metabolism should be investigated more 
comprehensively.     
4.2.2.4 Why does an apple a day to keep the doctor away? 
From the studies included in this project fresh apple seems to be a health promoting food item 
with the ability to reduce total and LDL cholesterol, increase total and primary bile acids, 
decrease secondary bile acids, and a higher capability to handle oxidative stress is indicated 
due to effects on gene expression responses related to glutathione formation and utilisation. 
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Additionally, urinary excretion of phenolics, polyphenols and potential metabolites involved 
in catecholamine and cholesterol metabolism point tentatively towards health promoting 
abilities of fresh apple, but since no firm evidence excists considering these markers, this is 
only mentioned cautiously as possible health effects.  It is important to state that these results 
were obtained from rat studies and that extrapolation to humans should be done carefully 
considering the aspects stated in section 4.1.2.  
To answer the question of ‘why does an apple a day to keep the doctor away?’ the soluble 
fibre fraction of apple, namely pectin, was inspected. Our investigations could not ascribe this 
component major health promoting effects, with regard to cholesterol metabolism, but it is 
worth mentioning that a much higher pectin dose was used as compared to the pectin dose 
naturally occuring in the apple. Consistent with our results Aprikian et al. (2003) found no 
effect of apple-pectin on total plasma cholesterol in rats, but a combined treatment with apple 
polyphenols, and apple-pectin showed a significant plasma cholesterol lowering effect. The 
plasma cholesterol-lowering effect we observed with fresh apple, and not with pectin alone 
(Paper III), may be caused by a combined effect of the polyphenol and pectin present in whole 
apple. However, we did not find total or LDL cholesterol lowering potential of dried apple-
powder, which contains both pectin and polyphenols, and the formulation of the bioactive 
components in the whole fruit matrix may instead be suggested as responsible for the health 
beneficial effects. It seems evident that the bioavailability of both the polyphenol fraction and 
the fibre fraction from apple are highly dependent on the composition and the competences of 
the host intestinal microbiota, and the apple matrix as a whole may be speculated to have a 
particularly beneficial prebiotic effect. 
 
  
53 
 
5 Conclusion  
During the research in this project MS and NMR-based metabolomics were employed as new 
approaches to evaluate the health effects of apple and pectin intake. The results from the three 
papers included in this thesis can be summarised as follows:  
• The application of a non-targeted MS-based metabolomics approach (Paper I) 
demonstrated that intake of apple and apple-pectin had a high impact on the urinary 
metabolome. Numerous clear exposure and effect markers of apple and apple-pectin 
intake were found and several new apple-related urinary metabolites were identified. 
Most of the excreted metabolites were products of diverse metabolic processes 
including phase II glucuronidation, glycine-conjugation and/or microbial metabolism.  
 
• A targeted NMR-based metabolomics approach facilitated construction of 
chemometric models (Paper II) capable of fast and reliable prediction of cholesterol in 
different lipoprotein fractions of stored rat plasma. Application of these models 
demonstrated a significant HDL cholesterol lowering effect of dried apple-powder in 
rats. 
 
• Based on the chemometric prediction models in Paper II, cholesterol in the different 
plasma lipoprotein fractions was predicted from rats fed with fresh apple or apple-
pectin (Paper III). Apple intake induced a significant decrease in plasma LDL, HDL 
and total cholesterol whereas pectin intake did not induce any significant changes in 
this aspect. Non-metabolomics measurements illustrated that apple increased excretion 
of bile acids and revealed significant effects on genes involved in the hepatic 
glutathione redox cycle indicating a higher capability to handle oxidative stress. Pectin 
only affected expression related to glutathione utilisation.  
 
In general, both the non-targeted and targeted MS and NMR-based metabolomics approach 
have served as powerful platforms during these studies, and the metabolomics technology 
seems very promising in further deconvolution of the interplay between dietary intake and 
health status. The investigation revealed overall that particularly fresh apple appears to have 
health beneficial effects on cholesterol metabolism, but from our results pectin cannot be 
appointed as the major apple component that caused this effect. The formulation of the 
bioactive components in the apple fruit matrix and the interaction with the intestinal 
microbiota seems of key importance for the potential health effects of apple. However, since 
these investigations were conducted with rat models, it is important to stress a careful 
extrapolation to man, and confirming experiments are warranted in humans.         
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6 Perspectives 
 
Metabolomics is a discipline dedicated to the study of metabolites, their dynamics, 
composition, interactions and responses to interventions or to changes in the environment. 
Numerous factors along the metabolomics pipeline have to be considered in the establishment 
of this technique to achieve successful and reliable results. Once firmly established, there 
seems to be various ways to use this technique, especially the use of every analytical run in a 
multipurpose approach seems promising. In this way the maximum yield can be gained from 
expensive intervention studies and possible new correlating variables or patterns among 
multiple samples and measurements can be revealed. For instance, plasma NMR spectra could 
provide a metabolite profile of around 100 known compounds, and at the same time the 
lipoprotein profile (even the subclasses of the lipoproteins) could be examined. Several other 
well-established disease risk markers may possibly be predicted at the same time from these 
same spectra. These results could again be compared with data from MS-based metabolomics, 
from which a much higher number of metabolites could be identified. However, the 
identification procedure of metabolites of interest is continuously a difficult and time-
consuming task, but fortunately databases are constantly growing in reported metabolites, 
making the task somewhat easier for the researcher. When a metabolite is appropriately 
identified it would be of high benefit to quantify this by a targeted analysis. In fact, the 
maximum gain of metabolomics may be obtained when qualitative and quantitative analysis is 
combined. The knowledge of metabolite identity and their quantitative perturbations will 
provide information that can be very useful in interpretation of affected biochemical 
pathways. 
A final way to combine and correlate data should be mentioned. An ultimate challenge 
includes on integration of the different ‘omics technologies: proteomics, genomics and 
metabolomics, to obtain a more complete picture of health status and in this way to unravel 
links between disease prevention and dietary intake. 
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